- HK$5.87bn
- HK$8.52bn
- CNY2.65bn
Brief: BlackRock Inc's Long Position In H-Shares Of Jinxin Fertility Rises To 5.17% - Filing
Brief: BlackRock Inc's Long Position In H-Share Of Jinxin Fertility Falls To 4.85% - Filing
Brief: BlackRock Inc's Long Position In H-Share Of Jinxin Fertility Rises To 5.0% - Filing
Brief: Jinxin Fertility Says Unit Announces Acquisition Of 90% Equity Interest In Jiuzhou Hospital And Hewanjia Hospital
Brief: Jinxin Fertility Announces Acquisition Of 5.46% Stake In Shenzhen Zhongshan Hospital
Brief: Jinxin Fertility Posts Revenue For Year Rmb1,838.8 Million, Increase Of 28.9%
Brief: Jinxin Fertility Says Unit To Buy Shenzhen Hengyu Lianxiang Investment Development Co
Brief: Jinxin Fertility Group To Acquire 15% Equity Interest In Shenzhen Zhongshan Hospital
Brief: Jinxin Fertility Group Says Lyu Rong Appointed As Executive Director
Brief: BlackRock Inc's Long Position In Jinxin Fertility Falls To 4.99% - HKEX Filing
Brief: Jinxin Fertility Group Announces Acquisition Of Entire Stake Of Jinxin Medical Management (BVI) Group
Brief: Jinxin Fertility Says HY Net Profit Rmb162.6 Million, Increase Of 31.7%
Brief: BlackRock Inc's Long Position In Jinxin Fertility Rises To 5.09% - HKEX Filing
Brief: BlackRock Inc's Long Position In Jinxin Fertility Falls To 4.76% - HKEX Filing
HK-listed Jinxin Fertility falls on reports of major shareholder's share sale
HK-listed Jinxin Fertility Group jumps on expansion deals
Brief: Jinxin Fertility's Unit To Buy 10% Equity Interest In Guangdong Kangzhi Hospital Management Co
Brief: Honz Pharma To Sell Hospital Mgt Firm, In Strategic Agreement With Jinxin Fertility
China's birth and fertility-related stocks fall after Moody's report